Urofollitrophin is a high-purity hormone obtained from the urine of
menopausal people, which has the effect of stimulating follicle development and
maturation. Sequential administration of urinary follicle-stimulating hormone
and chorionic gonadotropin (HCG) can promote ovulation in patients with
polycystic ovaries (the LH/FSH value of these patients is elevated, and
clomiphene therapy is ineffective).
The prohibition of using urofollicle-stimulating hormones enumerates:
Patients who are allergic to the urofollicle-stimulating hormone are
contraindicated.
Those with ovarian, breast, uterine, hypothalamic, or pituitary tumors are
prohibited.
Primary ovarian failure is disabled.
Patients with ovarian cysts unrelated to polycystic ovaries or ovarian
enlargement are contraindicated.
Disabled for undiagnosed vaginal bleeding.
It is contraindicated for those with abnormal sex organs who are not
suitable for pregnancy.
Uterine fibroids are not suitable for pregnant women.
Pregnant and lactating women please do not use.
The above is the relevant content of Urofollitropin Instructions. If you
also have Human chorionic gonadotropin API Supplier, Human Menopausal
Gonadotropin supplier, Urofollitropin price, Urokinase manufacturer, Hormone API
Manufacturer, and other needs, you can directly contact Kangyuan by phone. We
have many years of industry experience in R&D and production The trusted
brand choice.